Rapid assessment of phenotypic resistance to protease inhibitors in human immunodeficiency virus type 1 group O

Journal of Clinical Microbiology

Volumn 40, Issue 11, 2002, Pages 4313-4316

  Rodés, Berta ^a   Poveda, Eva ^a   Soriano, Vincent ^a  

^a NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; LAMIVUDINE; PROTEINASE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; AMINO ACID SUBSTITUTION; ANALYTIC METHOD; ARTICLE; BACTERIOPHAGE LAMBDA; CASE REPORT; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; VIRUS ISOLATION; VIRUS RESISTANCE;

ADULT; AMINO ACID SEQUENCE; BACTERIOPHAGE LAMBDA; DRUG RESISTANCE, VIRAL; FEMALE; HIV PROTEASE; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; INDINAVIR; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PHENOTYPE; SAQUINAVIR; TIME FACTORS;

BACTERIOPHAGE LAMBDA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0036840267     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.11.4313-4316.2002     Document Type: Article

References (17)

1. Charneau, P., A. M. Borman, C. Quillent, D. Guetard, S. Chamaret, J. Cohen, G. Remy, L. Montagnier, and F. Clavel. 1994. Isolation and envelope sequence of highly divergent HIV-1 isolate: Definition of a new HIV-1 group. Virology 205:247-253.
2. Coffin, J. M., H. S. Hughes, and H. E. Varmus. 1997. Retroviruses. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
3. De Baar, M. P., W. Janssens, A. De Ronde, K. Fransen, R. Colebounders, L. Kestens, G. Van Der Groen, and J. Goudsmit. 2000. Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O transcriptase and protease related to virological drug failure in vivo. AIDS Res. Hum. Retrovir. 16:1385-1394.
4. De Mendoza, C., W. Lu, A. Machuca, M. Sainz, J. Castilla, and V. Soriano. 2001. Monitoring the response to antiretroviral therapy in HIV-1 group O infected patients using two new RT-PCR assays. J. Med. Virol. 64:217-222.
5. Descamps, D., G. Collin, F. Letourneur, C. Apetrei, F. Damond, I. LoussertAjaka, F. Simon, S. Saragosti, and F. Brun-Vézinet. 1997. Susceptibility of HIV type 1 group O isolates to antiretroviral agents: In vitro phenotypic and genetic analyses. J. Virol. 71:8893-8898.
6. Garcia Lerma, J. G., M. Gutierrez, A. Mas, R. Bravo, O. Aguilera, and V. Soriano. 1996. Report of the first two cases of HIV-1 group O infection in Spain. Med. Clin. (Barcelona) 107:418-421.
7. Jaffe, H. W., and G. Schochetman. 1998. Group O human immunodeficiency virus type 1 infections. Infect. Dis. Clin. N. Am. 12:39-46.
8. Luk, K. C., L. Kaptue, L. Zekeng, V. Soriano, L. Gurtler, S. G. Devare, G. Schochetman, and J. Hackett, Jr. 2001. Naturally occurring sequence polymorphisms within HIV type 1 group O protease. AIDS Res. Hum. Retrovir. 17:1555-1561.
9. Martinez, M. A., M. Cabana, M. Parera, A. Gutierrez, J. A. Esté, and B. Clotet. 2000. A bacteriophage lambda-based genetic screening for characterization of the activity and phenotype of the HIV type 1 protease. Antimicrob. Agents Chemother. 44:1132-1139.
10. Nkengasong, J. N., K. Fransen, B. Willens, E. Karita, J. Vingerhoets, L. Kestens, R. Colebunders, P. Plot, and G. Van der Groen. 1997. Virologic, immunologic, and clinical follow-up of a couple infected by HIV-1 group O. J. Med. Virol. 51:202-209.
11. Quifiones-Mateu, M. E., J. A. Albright, A. Mas, V. Soriano, and E. J. Arts. 1998. Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of HIV type 1. J. Virol. 72:9002-9015.
12. Quifiones-Mateu, M. E., V. Soriano, E. Domingo, and L. Menendez-Arias. 1997. Characterization of the reverse transcriptase of a HIV type 1 group O isolate. Virology 236:364-373.
13. Robertson, D. L., J. P. Anderson, J. A. Bradac, J. K. Carr, B. Foley, R. K. Funkhouser. 1999. HIV-1 nomenclature proposal: a reference guide to HIV-1 classification, p. 234-248. In C. L. Kuiken, B. Foley, and B. Hahn (ed.), Human Retroviruses and AIDS. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos N.Mex.
14. Schinazi, R. F., B. A. Larder, and J. W. Mellors. 1999. Resistance table: Mutations in retroviral genes associated with drug resistance: 1999-2000 Update. Int. Antivir. News 7:46-68.
15. Shafer, R. W., R. Kantor, and M. J. Gonzales. 2000. The genetic basis of HIV-1 resistance to reverse transcriptase and protease inhihitors. AIDS Rev. 2:211-228.
16. Sices, H. J., and T. M. Kristie. 1998. A genetic screening method for the isolation and characterization of site-specific proteases. Proc. Natl. Acad. Sci. USA 95:2828-2833.
17. Sices, H. J., M. Leusink, A. Pacheco, and T. Kristie. 2001. Rapid genetic selection of inhibitor-resistant protease mutants: Clinically relevant and novel mutants of the HIV protease. AIDS Res. Hum. Retrovir. 17:1249-1255.